Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

1.

Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma.

Cruz-Muñoz W, Jaramillo ML, Man S, Xu P, Banville M, Collins C, Nantel A, Francia G, Morgan SS, Cranmer LD, O'Connor-McCourt MD, Kerbel RS.

Cancer Res. 2012 Oct 1;72(19):4909-19. doi: 10.1158/0008-5472.CAN-12-2194. Epub 2012 Aug 3.

PMID:
22865454
[PubMed - indexed for MEDLINE]
Free Article
2.

CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.

Wuttig D, Zastrow S, Füssel S, Toma MI, Meinhardt M, Kalman K, Junker K, Sanjmyatav J, Boll K, Hackermüller J, Rolle A, Grimm MO, Wirth MP.

Int J Cancer. 2012 Sep 1;131(5):E693-704. doi: 10.1002/ijc.27419. Epub 2012 Feb 28.

PMID:
22213152
[PubMed - indexed for MEDLINE]
3.

Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor.

Montgomery JP, Patterson PH.

BMC Cancer. 2008 Nov 28;8:354. doi: 10.1186/1471-2407-8-354.

PMID:
19040731
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas.

Lahav R, Suvà ML, Rimoldi D, Patterson PH, Stamenkovic I.

Cancer Res. 2004 Dec 15;64(24):8945-53.

PMID:
15604257
[PubMed - indexed for MEDLINE]
Free Article
5.

Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.

Cruz-Munoz W, Man S, Xu P, Kerbel RS.

Cancer Res. 2008 Jun 15;68(12):4500-5. doi: 10.1158/0008-5472.CAN-08-0041.

PMID:
18559492
[PubMed - indexed for MEDLINE]
Free Article
6.

Endothelin receptor B is required for the expansion of melanocyte precursors and malignant melanoma.

Lahav R.

Int J Dev Biol. 2005;49(2-3):173-80. Review.

PMID:
15906230
[PubMed - indexed for MEDLINE]
Free Article
7.

Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival.

Smith SL, Damato BE, Scholes AG, Nunn J, Field JK, Heighway J.

Br J Cancer. 2002 Nov 18;87(11):1308-13.

PMID:
12439722
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Imatinib mesylate alters the expression of genes related to disease progression in an animal model of uveal melanoma.

Fernandes BF, Di Cesare S, Neto Belfort R, Maloney S, Martins C, Castiglione E, Isenberg J, Abourbih D, Antecka E, Burnier MN Jr.

Anal Cell Pathol (Amst). 2011;34(3):123-30. doi: 10.3233/ACP-2011-0010.

PMID:
21606571
[PubMed - indexed for MEDLINE]
9.

Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.

Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.

Oncogene. 2006 Dec 7;25(58):7618-34. Epub 2006 Sep 18. Erratum in: Oncogene. 2007 Feb 22;26(8):1256.

PMID:
16983347
[PubMed - indexed for MEDLINE]
10.

Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer.

J Natl Cancer Inst. 2006 Apr 5;98(7):472-82.

PMID:
16595783
[PubMed - indexed for MEDLINE]
Free Article
11.

Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors.

Némati F, Sastre-Garau X, Laurent C, Couturier J, Mariani P, Desjardins L, Piperno-Neumann S, Lantz O, Asselain B, Plancher C, Robert D, Péguillet I, Donnadieu MH, Dahmani A, Bessard MA, Gentien D, Reyes C, Saule S, Barillot E, Roman-Roman S, Decaudin D.

Clin Cancer Res. 2010 Apr 15;16(8):2352-62. doi: 10.1158/1078-0432.CCR-09-3066. Epub 2010 Apr 6. Erratum in: Clin Cancer Res. 2010 Jul 15;16(14):3807.

PMID:
20371695
[PubMed - indexed for MEDLINE]
Free Article
12.

The role of interleukin 1 in growth and metastasis of human cancer xenografts.

Elaraj DM, Weinreich DM, Varghese S, Puhlmann M, Hewitt SM, Carroll NM, Feldman ED, Turner EM, Alexander HR.

Clin Cancer Res. 2006 Feb 15;12(4):1088-96.

PMID:
16489061
[PubMed - indexed for MEDLINE]
Free Article
13.

The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.

Izraely S, Sagi-Assif O, Klein A, Meshel T, Tsarfaty G, Pasmanik-Chor M, Nahmias C, Couraud PO, Ateh E, Bryant JL, Hoon DS, Witz IP.

Int J Cancer. 2012 Sep 1;131(5):1071-82. doi: 10.1002/ijc.27324. Epub 2011 Dec 2.

PMID:
22025079
[PubMed - indexed for MEDLINE]
14.

Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression.

Bagnato A, Rosanò L, Spinella F, Di Castro V, Tecce R, Natali PG.

Cancer Res. 2004 Feb 15;64(4):1436-43.

PMID:
14973117
[PubMed - indexed for MEDLINE]
Free Article
15.

Endothelin-B receptor blockade inhibits molecular effectors of melanoma cell progression.

Rosanò L, Spinella F, Genovesi G, Di Castro V, Natali PG, Bagnato A.

J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S136-9.

PMID:
15838263
[PubMed - indexed for MEDLINE]
16.

Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes.

Eberle J, Weitmann S, Thieck O, Pech H, Paul M, Orfanos CE.

J Invest Dermatol. 1999 Jun;112(6):925-32.

PMID:
10383740
[PubMed - indexed for MEDLINE]
Free Article
17.

Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity.

Ghosh R, Nadiminty N, Fitzpatrick JE, Alworth WL, Slaga TJ, Kumar AP.

J Biol Chem. 2005 Feb 18;280(7):5812-9. Epub 2004 Dec 1.

PMID:
15574415
[PubMed - indexed for MEDLINE]
Free Article
18.

Rapid identification of dysregulated genes in cutaneous malignant melanoma metastases using cDNA technology.

Mirmohammadsadegh A, Baer A, Nambiar S, Bardenheuer W, Hengge UR.

Cells Tissues Organs. 2004;177(3):119-23.

PMID:
15388985
[PubMed - indexed for MEDLINE]
19.

Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.

Nambiar S, Mirmohammadsadegh A, Doroudi R, Gustrau A, Marini A, Roeder G, Ruzicka T, Hengge UR.

Arch Dermatol. 2005 Feb;141(2):165-73.

PMID:
15724012
[PubMed - indexed for MEDLINE]
20.

Bcl-2 protein in 518A2 melanoma cells in vivo and in vitro.

Benimetskaya L, Ayyanar K, Kornblum N, Castanotto D, Rossi J, Wu S, Lai J, Brown BD, Popova N, Miller P, McMicken H, Chen Y, Stein CA.

Clin Cancer Res. 2006 Aug 15;12(16):4940-8.

PMID:
16914583
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk